Rates and Correlates of Potentially Inappropriate Colorectal Cancer Screening in the Veterans Health Administration

Journal of General Internal Medicine

Volumn 30, Issue 6, 2015, Pages 732-741

  Powell, Adam A ^a,b   Saini, Sameer D ^c,d   Breitenstein, Matthew K ^a,e   Noorbaloochi, Siamak ^a,b   Cutting, Andrea ^a   Fisher, Deborah A ^f,g   Bloomfield, Hanna E ^a,b   Halek, Krysten ^a   Partin, Melissa R ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

colorectal cancer; practice variation; screening; utilization; Veterans

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT RISK; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; SCREENING TEST; TREATMENT INDICATION; VETERANS HEALTH; AGED; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; GOVERNMENT; HEALTH SERVICE; MASS SCREENING; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; VERY ELDERLY; VETERAN;

AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES MISUSE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; VETERANS HEALTH;

EID: 84929837276     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-3163-8     Document Type: Article

References (32)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–117.
2. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(2):132–141.
3. Department of Veterans Affairs Veterans Health Administration. 2010 VHA facility quality and safety report. http://www.va.gov/health/docs/HospitalReportCard2010.pdf. Accessed December 11, 2014.
4. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Centers for Disease Control and Prevention (CDC). Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008. Morb Mortal Wkly Rep Surveill Summ. 2011;60:42–46.
5. US Preventive Services. Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637.
6. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: A decision analysis for the US Preventive Services Task Force. Ann Intern Med. 2008;149(9):659–669.
7. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: Meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441.
8. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–1595.
9. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–658.
10. Ko CW, Dominitz JA. Complications of colonoscopy: Magnitude and management. Gastrointest Endosc Clin N Am. 2010;20(4):659–671.
11. Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: Findings and implications. Am J Gastroenterol. 2005;100(11):2526–2530.
12. Ahmed FMD, Murthy UKMD. Inappropriate and improper use of fecal occult blood tests for colorectal cancer screening in the VA medical system. Am J Gastroenterol. 2006;101(6):1401.
13. Sheffield KM, Han Y, Kuo Y, Riall TS, Goodwin JS. Potentially inappropriate screening colonoscopy in Medicare patients: Variation by physician and geographic region. JAMA Intern Med. 2013;173(7):542–550.
14. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171(15):1335–1343.
15. Partin MR, Powell AA, Bangerter A, et al. Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration. J Gen Intern Med. 2012;27(12):1618–1625.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–383.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
18. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006: A population-based cohort study. Dis Colon Rectum. 2009;52(1):71–78.
19. Cho H, Klabunde CN, Yabroff KR, et al. Comorbidity-adjusted life expectancy: A new tool to inform recommendations for optimal screening strategies. Ann Intern Med. 2013;159(10):667–676.
20. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–2342.
21. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–473.
22. US preventive services task force: Screening for colorectal cancer. http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Accessed December 11, 2014.
23. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–2091.
24. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389–394.
25. Partin M, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes and Control. 2010;21(9):1357–1368.
26. Stefos T, LaVallee N, Holden F. Fairness in prospective payment: A clustering approach. Health Serv Res. 1992;27(2):239.
27. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232–1235.
28. Etzioni DA, Yano EM, Rubenstein LV, et al. Measuring the quality of colorectal cancer screening: The importance of follow-up. Dis Colon Rectum. 2006;49(7):1002–1010.
29. Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader JP, Gonvers JJ. Use, appropriateness, and diagnostic yield of screening colonoscopy: An international observational study (EPAGE). Gastrointest Endosc. 2006;63(7):1018–1026.
30. Baron TH, Kimery BD, Sorbi D, Gorkis LC, Leighton JA, Fleischer DE. Strategies to address increased demand for colonoscopy: Guidelines in an open endoscopy practice. Clin Gastroenterol Hepatol. 2004;2(2):178–182.
31. Mahajan RJ, Barthel JS, Marshall JB. Appropriateness of referrals for open-access endoscopy: How do physicians in different medical specialties do? Arch Intern Med. 1996;156(18):2065–2069.
32. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881–888.